Approach to contraception in the primary health care: barrier, behavioral and pharmaceutical methods

Shada Omar Baoum, Zainab Abduljabbar Almomen, Fatmah Abdullah Alotaibi, Rawan Ayedh Almohaiya, Amani Abdullah Alharbi, Hamed Arif Hejazi, Hibah Abdullah Alsabei, Norah Salem Algethami, Nareman Sulaiman Shamlan, Norah Dakhilallah Aljohani, Nura Ayidh Alqahtani


Contraception is a critical tool in achieving favorable family planning, which has been reported with remarkable outcomes on the individual and country-based levels. Using contraceptive approaches has been reported to be cost efficacious with minimal side effects. It gives couples more freedom, privacy and control over their lives, which might also enhance the quality of life of these individuals. In the present study, we have reviewed evidence from current studies in the literature about the different approaches to contraception in primary care. We have discussed the different barrier and non-barrier approaches that have been validated in the literature as efficacious approaches that can achieve contraception. We also reviewed the safety profiles for the different modalities and whether they can be used or not. Overall, couples should consult with the primary care physician before approaching any modality to give them a better judgment about the potential benefits and risks of each suitable contraception tool. We suggest that educational campaigns should also be conducted to increase awareness and attitude about family planning and using contraceptive modalities to expand the application and favorable outcomes of using these tools.


Contraception, Barrier, Non-barrier, Pharmaceutical, Oral contraceptive pills

Full Text:



Jain R, Muralidhar S. Contraceptive methods: needs, options and utilization. J Obstetr Gynaecol India. 2011;61(6):626-34.

Colquitt CW, Martin TS. Contraceptive methods. J Pharma Pract. 2017;30(1):130-5.

Bromham DR. STD prevention and unplanned pregnancies in Great Britain. Contracepti Fertilit Sexualit. 1995;23(4):255-7.

Stricker R, Eberhart R, Chevailler MC, Quinn FA, Bischof P, Stricker R. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clinic Chem Lab Med. 2006;44(7):883-7.

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception. 1996;54(3):1-106.

Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000;284(14):1791-8.

Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, et al. Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE study group. Steroid Hormones and reproductions. Am J Epidemiol. 2000;152(3):233-41.

Sulak PJ. Oral contraceptives: therapeutic uses and quality-of-life benefits-case presentations. Contraception. 1999;59(1):35-8.

Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, et al. Modern oral contraceptives and cardiovascular disease. Am J Obstetr Gynecol. 1997;177(3):707-15.

Consensus conference on combination oral contraceptives and cardiovascular disease. Fertil Steril. 1999;71:1-6.

Chen FC, vonDehn D, Büscher U, Dudenhausen JW, Niggemann B. Atopy, the use of condoms, and a history of cesarean delivery: potential predisposing factors for latex sensitization in pregnant women. Am J Obstetr Gynecol. 1999;181(6):1461-4.

Schivone G, Dorflinger L, Halpern V. Injectable contraception: updates and innovation. Curr Opin Obstetr Gynecol. 2016;28(6):504-9.

Upadhyay UD, Zlidar VM, Foster DG. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States. Contraception. 2016;94(4):303-13.

Trussell J, Guthrie K. Choosing a contraceptive: Efficacy, safety, and personal considerations. Contracept Technol. 2007:45-74.

Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397-404.

Hohmann H, Creinin MD. The contraceptive implant. Clinic Obstetr Gynecol. 2007;50(4):907-17.

Etonogestrel implant (Implanon) for contraception. Drug Therapeut Bull. 2001;39(8):57-9.

Darney PD. Implantable contraception. Eur J Contracept Reproduct Health Care. 2000;5(2):2-11.

Funk S, Miller MM, Mishell DR, Archer DF, Poindexter A, Schmidt J, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71(5):319-26.

Ali M, Bahamondes L, Landoulsi S. Extended effectiveness of the etonogestrel-releasing contraceptive implant and the 20 µg levonorgestrel-releasing intrauterine system for 2 years beyond U.S. food and drug administration product labeling. Glob Health Sci Pract. 2017;5(4):534-9.

McNicholas C, Swor E, Wan L, Peipert JF. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond food and drug administration-approved duration. Am J Obstetr Gynecol. 2017;216(6):586.

Abrams LS, Skee DM, Natarajan J, Wong FA, Anderson GD. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites. Br J Clin Pharmacol. 2002;53(2):141-6.

Parasrampuria DA, Vaughan S, Ariyawansa J, Swinnen A, Natarajan J, Rasschaert F, et al. Comparison of a transdermal contraceptive patch with a newly sourced adhesive component versus EVRA patch: a double-blind, randomized, bioequivalence and adhesion study in healthy women. Contraception. 2020;101(4):276-82.

Gruber D, Skřivánek A, Serrani M, Lanius V, Merz M. A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Contraception. 2015;91(2):105-12.

Roumen F. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. Eur J Contracept Reproduct Health Care. 2002;7(2):19-24.

Ethinylestradiol+etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations. Prescrire Int. 2006;15(82):50-3.

Bruni V, Pontello V, Luisi S, Petraglia F. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing. Eur J Obstetr Gynecol Reproduct Biol. 2008;139(1):65-71.

Kerns J, Darney P. Vaginal ring contraception. Contraception. 2011;83(2):107-15.

Odlind V. Modern intra-uterine devices. Bailliere Clinic Obstetr Gynaecol. 1996;10(1):55-67.

Monaco J, Zolotor A. Optimal use of IUDs: why aren't we there yet? Am Fam Physician. 2014;89(6):434.

Intrauterine devices: an effective alternative to oral hormonal contraception. Prescrire Int. 2009;18(101):125-30.

Fortney JA, Feldblum PJ, Raymond EG. Intrauterine devices. The optimal long-term contraceptive method? J Reproduct Med. 1999;44(3):269-74.

Hardeman J, Weiss BD. Intrauterine devices: an update. Am Fam Physician. 2014;89(6):445-50.

Edwardson J, Jamshidi R. The contraceptive vaginal ring. Semin Reproduct Med. 2010;28(2):133-9.

Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L. Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial. Perspect Sex Reproduct Health. 2003;35(2):79-86.

Gallo MF, Grimes DA, Schulz KF. Nonlatex vs. latex male condoms for contraception: a systematic review of randomized controlled trials. Contraception. 2003;68(5):319-26.

Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ. Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial. Obstetr Gynecol. 2003;101(3):539-47.

McNamee K. The female condom. Austral Fam Physician. 2000;29(6):555-7.

Trussell J, Strickler J, Vaughan B. Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Fam Plan Perspect. 1993;25(3):100-5.

Richardson BA. Nonoxynol-9 as a vaginal microbicide for prevention of sexually transmitted infections: it's time to move on. JAMA. 2002;287(9):1171-2.

Secor RM. The cervical cap. NAACOG Clinic Issue Perinat Women Health Nurs. 1992;3(2):236-45.

Smith M, Barwin BN. Vaginal mechanical contraceptive devices. Canad Med Assoc J. 1983;129(7):699-701.

Wilcox AJ, Dunson DB, Weinberg CR, Trussell J, Baird DD. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception. 2001;63(4):211-5.

Lopez LM, Grey TW, Chen M, Denison J, Stuart G. Behavioral interventions for improving contraceptive use among women living with HIV. Coch Database Systemat Rev. 2016;2016(8):010243.